Quarterly report · Q2
9158.TEDINET S100S8BL
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥15.3bn | 2023-04-01 → 2023-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥7.7bn | 2023-07-01 → 2023-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥35.2bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥18.7bn | 2022-04-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥8.6bn | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Operating income | ¥1.8bn | 2023-04-01 → 2023-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥945m | 2023-07-01 → 2023-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥2.3bn | 2022-04-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥900m | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥1.7bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥887m | 2023-07-01 → 2023-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥3.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥2.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥897m | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥1.0bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥557m | 2023-07-01 → 2023-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥1.5bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥597m | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥1.0bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥556m | 2023-07-01 → 2023-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥1.5bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥595m | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥58.8bn | at 2023-09-30 | Cons. | Assets IFRS |
| Total assets | ¥39.8bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥34.1bn | at 2022-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥32.8bn | at 2023-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥27.8bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥26.0bn | at 2023-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥11.9bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥11.3bn | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥9.7bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥25.8bn | at 2023-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥11.7bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥11.0bn | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥20.0bn | at 2023-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥4.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥3.3bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥4.4bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥2.3bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | −¥243m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥2.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥6.7bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥1.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥16.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥4.0bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥578m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥40.09 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥19.13 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥113.9 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥72.37 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥28.62 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥40.09 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥19.13 | 2023-07-01 → 2023-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥113.9 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥72.37 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥28.62 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 43.8% | at 2023-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 29.4% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 32.3% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 96
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥98m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-07-01 → 2023-09-30 | ¥49m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥98m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-07-01 → 2023-09-30 | ¥49m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-07-01 → 2023-09-30 | ¥1m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥290m |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-09-30 | −¥157m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥290m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-09-30 | −¥157m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥576m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-09-30 | −¥288m |
| jpcrp040300-q2r_E37214-000Hospicereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.7bn |
| jpcrp040300-q2r_E37214-000Hospicereportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥2.5bn |
| jpcrp040300-q2r_E37214-000Hospicereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.7bn |
| jpcrp040300-q2r_E37214-000Hospicereportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥2.5bn |
| jpcrp040300-q2r_E37214-000Hospicereportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥63m |
| jpcrp040300-q2r_E37214-000Hospicereportable segment | segment profit | 2023-07-01 → 2023-09-30 | ¥66m |
| jpcrp040300-q2r_E37214-000In Home Nursingreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥5.5bn |
| jpcrp040300-q2r_E37214-000In Home Nursingreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E37214-000In Home Nursingreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥5.5bn |
| jpcrp040300-q2r_E37214-000In Home Nursingreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E37214-000In Home Nursingreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥386m |
| jpcrp040300-q2r_E37214-000In Home Nursingreportable segment | segment profit | 2023-07-01 → 2023-09-30 | ¥211m |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥5.3bn |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥5.0bn |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥290m |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥157m |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | segment profit | 2023-07-01 → 2023-09-30 | ¥954m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥15.5bn |
| —segment total | revenue | 2023-07-01 → 2023-09-30 | ¥7.8bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥15.2bn |
| —segment total | revenue external | 2023-07-01 → 2023-09-30 | ¥7.6bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥290m |
| —segment total | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥157m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| —segment total | segment profit | 2023-07-01 → 2023-09-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-09-30 | ¥7.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥15.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-09-30 | ¥7.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥290m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥157m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-09-30 | ¥1.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥99m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-07-01 → 2022-09-30 | ¥48m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥99m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-07-01 → 2022-09-30 | ¥48m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-07-01 → 2022-09-30 | ¥4m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥108m |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-09-30 | −¥52m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥108m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-09-30 | −¥52m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥386m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥197m |
| jpcrp040300-q2r_E37214-000Hospicereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥3.0bn |
| jpcrp040300-q2r_E37214-000Hospicereportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E37214-000Hospicereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥3.0bn |
| jpcrp040300-q2r_E37214-000Hospicereportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E37214-000Hospicereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥196m |
| jpcrp040300-q2r_E37214-000Hospicereportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥112m |
| jpcrp040300-q2r_E37214-000In Home Nursingreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥6.4bn |
| jpcrp040300-q2r_E37214-000In Home Nursingreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E37214-000In Home Nursingreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥6.4bn |
| jpcrp040300-q2r_E37214-000In Home Nursingreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E37214-000In Home Nursingreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥832m |
| jpcrp040300-q2r_E37214-000In Home Nursingreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥332m |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥9.3bn |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥4.0bn |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥9.2bn |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥3.9bn |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥108m |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥52m |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E37214-000Management Supportreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥649m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥18.7bn |
| —segment total | revenue | 2022-07-01 → 2022-09-30 | ¥8.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥18.6bn |
| —segment total | revenue external | 2022-07-01 → 2022-09-30 | ¥8.5bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥108m |
| —segment total | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥52m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥2.7bn |
| —segment total | segment profit | 2022-07-01 → 2022-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥18.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2022-09-30 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥18.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2022-09-30 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥108m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥52m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2022-09-30 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 987
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 29990400 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 29990400 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 29990400 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 29990400 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 18600000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.6345 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 2745000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0936 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 1820000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0621 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 1214000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0414 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 870000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0297 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 414000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0141 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 336000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0115 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 334000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0114 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 320000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0109 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 215000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0073 | |
| Number of shares held | CurrentQuarterInstant | 26869000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.9166 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 675000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 29313700 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 293137 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | 1700 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 29990400 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 293137 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 675000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 675000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0225 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 675000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 675000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0225 | |
| Cash and cash equivalents IFRS | Prior1YearInstant | 4120000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 20004000000 | JPY |
| Trade and other receivables ca IFRS | Prior1YearInstant | 8240000000 | JPY |
| Trade and other receivables ca IFRS | CurrentQuarterInstant | 8155000000 | JPY |
| Inventories ca IFRS | Prior1YearInstant | 44000000 | JPY |
| Inventories ca IFRS | CurrentQuarterInstant | 40000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |